Searched for
GSK PHARMA STOCK
Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
- Zydus Lifesciences buyback alert! Last date to buy shares to participate in Rs 1,100 crore buyback at 7% premiumInvestors must purchase Zydus Lifesciences shares by Wednesday, May 27, to be eligible for the Rs 1,100 crore buyback, as the record date i...
- Dividend alert! Last date to buy Bajaj Auto, GSK Pharma and 10 other stocks for solid payouts. Details hereTwelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...
- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
- GSK Pharma sheds 2% as Q3 profit drops, expenses riseTotal income in October-December 2021 stood at Rs 826.24 crore as compared with Rs 805.89 crore in the year-ago period, PTI reported.
- Trending stocks: Shares of GSK Pharma gain 4%The stock quoted a 52-week high of Rs 1744.0 and a 52-week low of Rs 1087.75.
- NSE rejigs indices: Here is the complete listScam-hit Punjab National Bank (PNB) will move out of the NSE's Nifty Midcap 100 index from April.
- Biocon, Piramal & GSK buck the pharma trend, outperform amid absence of FDA issuesWhile most pharma companies have turned risky on account of regulatory clamps, investors have switched to companies with healthy pipeline a...
- Sun Pharma hits fresh 52-week high, gains over 8% intraday on plans to buy GSK unitThe global Opiates market holds good potential and the addition of GSK’s Opiates business will strengthen Sun's positioning further, says A...
- Sun Pharma acquires GSK's opiates business in Australia as part of niche foray strategyThe acquisition will give Sun a product portfolio consisting of poppy-derived opiate raw material — mainly used to make painkillers.
- Bulls on the rampage, tailwinds take FMCG, pharma to fresh highsSharp drop in crude prices, slowing rate of inflation and downward trend in the interest rate cycle have created strong tailwinds for consu...
- Pick-up in local market boosts pharma MNCsA pick-up in the local pharma market augurs well for MNCs which are still recovering from the adverse impact of drug price control on high-...
- Novartis buys GSK's cancer drugs for $14.5 billion in a 3-way dealThe collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.
- GSK Pharma open offer begins today; stock hits 52-week highGSK Pharma continued to attract investor attention after its UK-based parent company GlaxoSmithKline’s voluntary open offer started today.
- GlaxoSmithKline Pharmaceuticals Q3 net up 4.44% at Rs 152.34 croreGlaxoSmithKline today reported 4.44 per cent rise in net profit at Rs 152.34 crore for the quarter ended September 30, 2012 on back of robu...
- Buy GSK Pharma: Ashwani GujralGSK Pharma which had a 5% move on Friday is now breaking out of its range that it had for about 2 to 3 months.
- Get into GSK Pharma at 2050-2000 levels: Ashwani Gujral"GSK in a range of 2050 to about 2450, it has been there for last odd 6 months. So chances are it will continue to stay there."
- Hold onto GSK Pharma: CK Narayan"GSK is a hold and you look to any big dips to buy."
- More drug MNCs join the stake-hike bandwagonAfter the two leading pharma multinationals recently increased their stakes in their Indian units, people connected with the industry say t...
Load More
